Lifitegrast

CAS 1025967-78-5 13 API suppliersSmall Molecule

Overview

Lifitegrast is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2048028).

API suppliers (13)

Suppliers of Lifitegrast evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India6Italy1Taiwan1Peru1China1

Country recorded for 10 of 13 suppliers.

9 of 13 hold a GMP certificate on record in the EU or UK registers

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Lifitegrast expires 18 Dec 2033. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
(2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid
Canonical SMILES
CS(=O)(=O)C1=CC=CC(=C1)C[C@@H](C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl
InChIKey
JFOZKMSJYSPYLN-QHCPKHFHSA-N
Verified Supplier Partner

Do you supply Lifitegrast? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.